39 results
Page 2 of 2
8-K
EX-99.2
q6gv2uglmq7dhvx
13 Oct 20
Gossamer Bio Announces Topline Results for Phase 2 Trials of Oral GB001 in Asthma and Chronic Rhinosinusitis
7:40am
8-K
EX-99.1
2qiwnf
24 Mar 20
Gossamer Bio Announces Fourth Quarter and Full-Year 2019 Financial Results and Provides Business Update
8:45am
10-Q
r0fdmry33s38 hmp
14 May 19
Quarterly report
7:47am
DEF 14A
9w9seqm 37w62fz
30 Apr 19
Definitive proxy
4:04pm
10-K
sbnnvzb49tk
22 Mar 19
Annual report
4:45pm
424B4
fip0np9sz7eb3lyrn
8 Feb 19
Prospectus supplement with pricing info
4:40pm
S-1/A
hey ro42dt2jen4z64
23 Jan 19
IPO registration (amended)
4:39pm
S-1/A
EX-10.5
d4oqncpoy3hdyz
23 Jan 19
IPO registration (amended)
4:39pm
S-1
EX-10.5
2agxow2qvp5i3
21 Dec 18
IPO registration
4:39pm
S-1
4vak66x0lz4
21 Dec 18
IPO registration
4:39pm
DRS/A
i09rbbs5snr
29 Nov 18
Draft registration statement (amended)
12:00am
DRS
mlvilf yi9vda
11 Oct 18
Draft registration statement
12:00am